Trial Condition(s):

Bacterial Infection

Ciprofloxacin (sequential IV/PO, Intravenous/Peroral) in pediatric cystic fibrosis patients with acute pulmonary exacerbation

Bayer Identifier:

Trial_1359

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
18
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Cipro IV (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information

Not Available